| transmembrane transport | GO:0055085 | 412 | 0.465 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.347 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.285 | |
| regulation of secretion | GO:0051046 | 274 | 0.237 | |
| response to radiation | GO:0009314 | 165 | 0.219 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.206 | |
| synaptic transmission | GO:0007268 | 329 | 0.205 | |
| skeletal system development | GO:0001501 | 356 | 0.181 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.167 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.120 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.117 | |
| striated muscle contraction | GO:0006941 | 45 | 0.114 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.111 | |
| pallium development | GO:0021543 | 120 | 0.110 | |
| cation transport | GO:0006812 | 399 | 0.109 | |
| calcium ion transmembrane transport | GO:0070588 | 85 | 0.106 | |
| regulation of system process | GO:0044057 | 200 | 0.101 | |
| response to light stimulus | GO:0009416 | 135 | 0.101 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.099 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.099 | |
| purkinje myocyte differentiation | GO:0003168 | 1 | 0.098 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.094 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.093 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.090 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.090 | |
| muscle tissue development | GO:0060537 | 308 | 0.090 | |
| regulation of cell migration | GO:0030334 | 219 | 0.087 | |
| blood circulation | GO:0008015 | 195 | 0.086 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.086 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.086 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.086 | |
| cardiac pacemaker cell fate commitment | GO:0060927 | 1 | 0.085 | |
| regulation of ion transmembrane transport | GO:0034765 | 119 | 0.082 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.082 | |
| spinal cord oligodendrocyte cell fate specification | GO:0021530 | 3 | 0.082 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.081 | |
| positive regulation of transcription via serum response element binding | GO:0010735 | 1 | 0.081 | |
| locomotory behavior | GO:0007626 | 195 | 0.078 | |
| regulation of ion transport | GO:0043269 | 215 | 0.077 | |
| lung development | GO:0030324 | 164 | 0.077 | |
| ventral spinal cord interneuron fate determination | GO:0060580 | 1 | 0.077 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.075 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.075 | |
| neuron migration | GO:0001764 | 122 | 0.074 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.073 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.072 | |
| forebrain development | GO:0030900 | 302 | 0.072 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.069 | |
| atrioventricular node cell development | GO:0060928 | 2 | 0.069 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.068 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.068 | |
| cellular homeostasis | GO:0019725 | 240 | 0.068 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.068 | |
| developmental maturation | GO:0021700 | 193 | 0.068 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.068 | |
| dorsal ventral neural tube patterning | GO:0021904 | 28 | 0.068 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.068 | |
| atrioventricular node cell fate commitment | GO:0060929 | 1 | 0.068 | |
| gtp catabolic process | GO:0006184 | 143 | 0.066 | |
| regulation of heart contraction | GO:0008016 | 77 | 0.066 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.066 | |
| plasma cell differentiation | GO:0002317 | 3 | 0.065 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.063 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.061 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.060 | |
| atrioventricular node cell differentiation | GO:0060922 | 2 | 0.060 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.059 | |
| smoothened signaling pathway | GO:0007224 | 105 | 0.059 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.058 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.057 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.057 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.057 | |
| cytosolic calcium ion homeostasis | GO:0051480 | 70 | 0.056 | |
| retinal cone cell development | GO:0046549 | 8 | 0.056 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.055 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.055 | |
| gtp metabolic process | GO:0046039 | 144 | 0.055 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.054 | |
| menarche | GO:0042696 | 1 | 0.053 | |
| protein targeting | GO:0006605 | 143 | 0.051 | |
| phototransduction | GO:0007602 | 17 | 0.051 | |
| regulation of cell motility | GO:2000145 | 236 | 0.051 | |
| atrial cardiac muscle cell development | GO:0055014 | 2 | 0.051 | |
| atrial cardiac muscle cell differentiation | GO:0055011 | 2 | 0.051 | |
| regulation of tube size | GO:0035150 | 57 | 0.050 | |
| respiratory tube development | GO:0030323 | 167 | 0.050 | |
| cell fate commitment | GO:0045165 | 210 | 0.050 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.050 | |
| male sex differentiation | GO:0046661 | 109 | 0.049 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.049 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.049 | |
| dephosphorylation | GO:0016311 | 129 | 0.049 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.049 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.048 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.048 | |
| ventricular cardiac muscle cell action potential | GO:0086005 | 4 | 0.047 | |
| axonogenesis | GO:0007409 | 274 | 0.047 | |
| septum transversum development | GO:0003343 | 2 | 0.047 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.047 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.046 | |
| organelle assembly | GO:0070925 | 177 | 0.046 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.046 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.045 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.044 | |
| cell fate determination involved in pattern specification | GO:0060582 | 1 | 0.044 | |
| cation homeostasis | GO:0055080 | 212 | 0.044 | |
| angiogenesis | GO:0001525 | 201 | 0.044 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.044 | |
| regulation of protein secretion | GO:0050708 | 82 | 0.044 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.044 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.043 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.043 | |
| membrane organization | GO:0061024 | 245 | 0.043 | |
| regulation of protein transport | GO:0051223 | 163 | 0.043 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.043 | |
| ventricular cardiac myofibril assembly | GO:0055005 | 3 | 0.043 | |
| epithelial cell development | GO:0002064 | 159 | 0.043 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.042 | |
| rhodopsin mediated signaling pathway | GO:0016056 | 4 | 0.042 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.042 | |
| telencephalon development | GO:0021537 | 186 | 0.041 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.040 | |
| cardiac ventricle development | GO:0003231 | 83 | 0.040 | |
| pulmonary myocardium development | GO:0003350 | 3 | 0.040 | |
| spinal cord oligodendrocyte cell differentiation | GO:0021529 | 3 | 0.040 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.040 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.040 | |
| lateral inhibition | GO:0046331 | 1 | 0.039 | |
| placenta development | GO:0001890 | 140 | 0.039 | |
| ribose phosphate biosynthetic process | GO:0046390 | 59 | 0.039 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.039 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.039 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.038 | |
| regulation of hormone secretion | GO:0046883 | 88 | 0.038 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.038 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.038 | |
| pancreatic pp cell differentiation | GO:0003312 | 2 | 0.038 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.037 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.037 | |
| detection of stimulus | GO:0051606 | 84 | 0.037 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.037 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.037 | |
| ear morphogenesis | GO:0042471 | 118 | 0.036 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.036 | |
| calcium ion transport | GO:0006816 | 159 | 0.036 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.036 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.036 | |
| microtubule based process | GO:0007017 | 236 | 0.036 | |
| cyclic nucleotide biosynthetic process | GO:0009190 | 44 | 0.036 | |
| glucose homeostasis | GO:0042593 | 128 | 0.036 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.036 | |
| endocytosis | GO:0006897 | 168 | 0.036 | |
| heart morphogenesis | GO:0003007 | 178 | 0.035 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.035 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.035 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.034 | |
| pancreatic pp cell fate commitment | GO:0003329 | 2 | 0.034 | |
| positive regulation of ion transport | GO:0043270 | 65 | 0.034 | |
| regulation of intrinsic apoptotic signaling pathway | GO:2001242 | 61 | 0.034 | |
| purine nucleotide biosynthetic process | GO:0006164 | 65 | 0.034 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.034 | |
| protein catabolic process | GO:0030163 | 221 | 0.034 | |
| visceral serous pericardium development | GO:0061032 | 2 | 0.034 | |
| germ cell development | GO:0007281 | 185 | 0.034 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.034 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.033 | |
| regulation of protein complex assembly | GO:0043254 | 83 | 0.033 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.033 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.033 | |
| regulation of transporter activity | GO:0032409 | 57 | 0.033 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.033 | |
| detection of light stimulus | GO:0009583 | 25 | 0.033 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.032 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.032 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.032 | |
| respiratory system development | GO:0060541 | 190 | 0.032 | |
| nucleotide biosynthetic process | GO:0009165 | 78 | 0.032 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.032 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.032 | |
| organelle fission | GO:0048285 | 170 | 0.031 | |
| regulation of metal ion transport | GO:0010959 | 106 | 0.031 | |
| cellular potassium ion transport | GO:0071804 | 43 | 0.031 | |
| stem cell development | GO:0048864 | 219 | 0.031 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.031 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.031 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.031 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.031 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.030 | |
| circulatory system process | GO:0003013 | 197 | 0.030 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.030 | |
| stem cell differentiation | GO:0048863 | 268 | 0.030 | |
| muscle system process | GO:0003012 | 141 | 0.030 | |
| metencephalon development | GO:0022037 | 89 | 0.030 | |
| endomembrane system organization | GO:0010256 | 147 | 0.029 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.029 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.029 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.029 | |
| cardiac muscle contraction | GO:0060048 | 32 | 0.029 | |
| purine containing compound biosynthetic process | GO:0072522 | 70 | 0.029 | |
| sa node cell to atrial cardiac muscle cell signalling | GO:0086018 | 4 | 0.029 | |
| regulation of neural retina development | GO:0061074 | 3 | 0.029 | |
| determination of left right symmetry | GO:0007368 | 80 | 0.029 | |
| myotube differentiation | GO:0014902 | 105 | 0.028 | |
| positive regulation of gtp catabolic process | GO:0033126 | 85 | 0.028 | |
| forebrain generation of neurons | GO:0021872 | 63 | 0.028 | |
| columnar cuboidal epithelial cell differentiation | GO:0002065 | 82 | 0.028 | |
| forebrain cell migration | GO:0021885 | 58 | 0.028 | |
| protein localization to membrane | GO:0072657 | 108 | 0.028 | |
| regulation of synaptic plasticity | GO:0048167 | 87 | 0.028 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.028 | |
| regulation of cardioblast differentiation | GO:0051890 | 3 | 0.028 | |
| retina morphogenesis in camera type eye | GO:0060042 | 45 | 0.027 | |
| regulation of peptide hormone secretion | GO:0090276 | 75 | 0.027 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.027 | |
| globus pallidus development | GO:0021759 | 2 | 0.027 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.026 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.026 | |
| type b pancreatic cell fate commitment | GO:0003327 | 1 | 0.026 | |
| photoreceptor cell maintenance | GO:0045494 | 19 | 0.026 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.026 | |
| bundle of his development | GO:0003166 | 4 | 0.026 | |
| sensory perception | GO:0007600 | 245 | 0.026 | |
| regulation of nucleotide biosynthetic process | GO:0030808 | 34 | 0.026 | |
| muscle cell development | GO:0055001 | 133 | 0.025 | |
| ribonucleotide biosynthetic process | GO:0009260 | 59 | 0.025 | |
| male gonad development | GO:0008584 | 88 | 0.025 | |
| heart contraction | GO:0060047 | 93 | 0.025 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.025 | |
| cellular response to inorganic substance | GO:0071241 | 37 | 0.025 | |
| positive regulation of endocytosis | GO:0045807 | 42 | 0.025 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.025 | |
| compound eye development | GO:0048749 | 1 | 0.025 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.025 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.025 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.025 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.025 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.025 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.025 | |
| protein targeting to vacuole | GO:0006623 | 3 | 0.025 | |
| regionalization | GO:0003002 | 337 | 0.025 | |
| striated muscle cell development | GO:0055002 | 125 | 0.024 | |
| positive regulation of nucleotide catabolic process | GO:0030813 | 88 | 0.024 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.024 | |
| purine ribonucleotide biosynthetic process | GO:0009152 | 59 | 0.024 | |
| cell recognition | GO:0008037 | 83 | 0.024 | |
| segmentation | GO:0035282 | 93 | 0.024 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.024 | |
| stem cell proliferation | GO:0072089 | 117 | 0.024 | |
| telencephalon cell migration | GO:0022029 | 55 | 0.024 | |
| phenol containing compound metabolic process | GO:0018958 | 60 | 0.024 | |
| primary neural tube formation | GO:0014020 | 95 | 0.024 | |
| spinal cord development | GO:0021510 | 81 | 0.023 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.023 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.023 | |
| regulation of ion transmembrane transporter activity | GO:0032412 | 54 | 0.023 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.023 | |
| epithelial cell morphogenesis | GO:0003382 | 41 | 0.022 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.022 | |
| neural retina development | GO:0003407 | 41 | 0.022 | |
| regulation of stem cell proliferation | GO:0072091 | 78 | 0.022 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.022 | |
| limb development | GO:0060173 | 166 | 0.022 | |
| g protein coupled acetylcholine receptor signaling pathway | GO:0007213 | 4 | 0.022 | |
| nucleoside phosphate biosynthetic process | GO:1901293 | 79 | 0.022 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.022 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.022 | |
| regulation of saliva secretion | GO:0046877 | 2 | 0.022 | |
| spinal cord patterning | GO:0021511 | 25 | 0.022 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.022 | |
| regulation of cation channel activity | GO:2001257 | 22 | 0.022 | |
| leukocyte migration | GO:0050900 | 124 | 0.022 | |
| regulation of endocytosis | GO:0030100 | 69 | 0.022 | |
| regulation of rho protein signal transduction | GO:0035023 | 71 | 0.021 | |
| positive regulation of ion transmembrane transporter activity | GO:0032414 | 15 | 0.021 | |
| ear development | GO:0043583 | 200 | 0.021 | |
| nuclear transport | GO:0051169 | 139 | 0.021 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.021 | |
| oviduct development | GO:0060066 | 3 | 0.021 | |
| amine metabolic process | GO:0009308 | 45 | 0.021 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.021 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.021 | |
| protein ubiquitination | GO:0016567 | 171 | 0.021 | |
| response to peptide | GO:1901652 | 136 | 0.021 | |
| photoreceptor cell development | GO:0042461 | 40 | 0.021 | |
| positive regulation of gtpase activity | GO:0043547 | 85 | 0.021 | |
| endocardial cushion to mesenchymal transition involved in heart valve formation | GO:0003199 | 4 | 0.021 | |
| inner medullary collecting duct development | GO:0072061 | 2 | 0.021 | |
| female gamete generation | GO:0007292 | 74 | 0.021 | |
| t cell activation | GO:0042110 | 289 | 0.021 | |
| dna metabolic process | GO:0006259 | 303 | 0.020 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.020 | |
| artery development | GO:0060840 | 53 | 0.020 | |
| spermatid development | GO:0007286 | 108 | 0.020 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.020 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.020 | |
| regulation of cyclic nucleotide metabolic process | GO:0030799 | 40 | 0.020 | |
| blood coagulation | GO:0007596 | 76 | 0.020 | |
| cyclic nucleotide metabolic process | GO:0009187 | 59 | 0.020 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.020 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.020 | |
| macromolecule methylation | GO:0043414 | 120 | 0.020 | |
| embryonic digit morphogenesis | GO:0042733 | 56 | 0.020 | |
| signal transduction involved in mitotic dna damage checkpoint | GO:1902402 | 3 | 0.020 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.020 | |
| oogenesis | GO:0048477 | 56 | 0.020 | |
| lipid transport | GO:0006869 | 98 | 0.020 | |
| eye photoreceptor cell development | GO:0042462 | 31 | 0.019 | |
| detection of external stimulus | GO:0009581 | 61 | 0.019 | |
| intracellular protein transport | GO:0006886 | 204 | 0.019 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.019 | |
| proepicardium development | GO:0003342 | 2 | 0.019 | |
| embryonic axis specification | GO:0000578 | 30 | 0.019 | |
| vesicle organization | GO:0016050 | 60 | 0.019 | |
| regulation of blood vessel size | GO:0050880 | 56 | 0.019 | |
| tube formation | GO:0035148 | 140 | 0.019 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.019 | |
| response to oxidative stress | GO:0006979 | 123 | 0.019 | |
| spinal cord dorsal ventral patterning | GO:0021513 | 23 | 0.019 | |
| neuroblast proliferation | GO:0007405 | 49 | 0.019 | |
| camera type eye development | GO:0043010 | 266 | 0.019 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.019 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.019 | |
| positive regulation of cardioblast differentiation | GO:0051891 | 3 | 0.019 | |
| cerebral cortex cell migration | GO:0021795 | 44 | 0.019 | |
| positive regulation of voltage gated calcium channel activity | GO:1901387 | 2 | 0.018 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.018 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.018 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.018 | |
| regulation of nuclear division | GO:0051783 | 56 | 0.018 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.018 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.018 | |
| sensory perception of mechanical stimulus | GO:0050954 | 107 | 0.018 | |
| left right pattern formation | GO:0060972 | 23 | 0.018 | |
| regulation of meiotic cell cycle | GO:0051445 | 34 | 0.018 | |
| detection of abiotic stimulus | GO:0009582 | 60 | 0.018 | |
| potassium ion transport | GO:0006813 | 52 | 0.018 | |
| immune effector process | GO:0002252 | 321 | 0.018 | |
| regulation of cell growth | GO:0001558 | 91 | 0.018 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.018 | |
| hindbrain development | GO:0030902 | 128 | 0.018 | |
| positive regulation of homeostatic process | GO:0032846 | 64 | 0.018 | |
| tertiary branching involved in mammary gland duct morphogenesis | GO:0060748 | 3 | 0.018 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.017 | |
| gland development | GO:0048732 | 330 | 0.017 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.017 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.017 | |
| neuron projection guidance | GO:0097485 | 141 | 0.017 | |
| gastrin induced gastric acid secretion | GO:0001698 | 1 | 0.017 | |
| cell division | GO:0051301 | 120 | 0.017 | |
| regulation of voltage gated calcium channel activity | GO:1901385 | 4 | 0.017 | |
| neural tube development | GO:0021915 | 160 | 0.017 | |
| regulation of ras gtpase activity | GO:0032318 | 88 | 0.017 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.017 | |
| ossification | GO:0001503 | 216 | 0.017 | |
| regulation of systemic arterial blood pressure | GO:0003073 | 61 | 0.017 | |
| peptide transport | GO:0015833 | 133 | 0.017 | |
| pancreatic a cell fate commitment | GO:0003326 | 2 | 0.017 | |
| limb morphogenesis | GO:0035108 | 149 | 0.017 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.017 | |
| chromatin modification | GO:0016568 | 187 | 0.017 | |
| maternal determination of anterior posterior axis embryo | GO:0008358 | 2 | 0.017 | |
| protein processing | GO:0016485 | 163 | 0.016 | |
| positive regulation of cytosolic calcium ion concentration | GO:0007204 | 65 | 0.016 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.016 | |
| negative regulation of cell motility | GO:2000146 | 61 | 0.016 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.016 | |
| establishment of protein localization to membrane | GO:0090150 | 54 | 0.016 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.016 | |
| cerebral cortex development | GO:0021987 | 86 | 0.016 | |
| purkinje myocyte development | GO:0003165 | 1 | 0.016 | |
| potassium ion transmembrane transport | GO:0071805 | 43 | 0.016 | |
| oocyte anterior posterior axis specification | GO:0007314 | 2 | 0.016 | |
| neural tube closure | GO:0001843 | 90 | 0.016 | |
| cgmp biosynthetic process | GO:0006182 | 13 | 0.016 | |
| neurotransmitter transport | GO:0006836 | 76 | 0.016 | |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 88 | 0.016 | |
| carbohydrate transport | GO:0008643 | 62 | 0.016 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.016 | |
| developmental induction | GO:0031128 | 34 | 0.016 | |
| sodium ion transmembrane transport | GO:0035725 | 49 | 0.016 | |
| protein kinase c activating g protein coupled receptor signaling pathway | GO:0007205 | 4 | 0.016 | |
| actomyosin structure organization | GO:0031032 | 56 | 0.016 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.016 | |
| neuropeptide signaling pathway | GO:0007218 | 19 | 0.016 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.016 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.016 | |
| embryonic placenta development | GO:0001892 | 98 | 0.016 | |
| photoreceptor cell differentiation | GO:0046530 | 52 | 0.016 | |
| regulation of circadian rhythm | GO:0042752 | 58 | 0.016 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.016 | |
| regulation of muscle system process | GO:0090257 | 80 | 0.015 | |
| response to oxygen levels | GO:0070482 | 62 | 0.015 | |
| skeletal muscle cell differentiation | GO:0035914 | 66 | 0.015 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.015 | |
| response to decreased oxygen levels | GO:0036293 | 59 | 0.015 | |
| sensory perception of chemical stimulus | GO:0007606 | 51 | 0.015 | |
| skin development | GO:0043588 | 220 | 0.015 | |
| nuclear division | GO:0000280 | 158 | 0.015 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.015 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.015 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.015 | |
| regulation of neural precursor cell proliferation | GO:2000177 | 70 | 0.015 | |
| lymphocyte activation involved in immune response | GO:0002285 | 93 | 0.015 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.015 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.015 | |
| protein secretion | GO:0009306 | 111 | 0.015 | |
| cell communication by chemical coupling | GO:0010643 | 2 | 0.015 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.015 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.015 | |
| limbic system development | GO:0021761 | 72 | 0.015 | |
| mucosal associated lymphoid tissue development | GO:0048537 | 12 | 0.015 | |
| defecation | GO:0030421 | 1 | 0.015 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.015 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.015 | |
| acid secretion | GO:0046717 | 33 | 0.015 | |
| histone modification | GO:0016570 | 159 | 0.015 | |
| negative regulation of wnt signaling pathway | GO:0030178 | 73 | 0.015 | |
| circadian rhythm | GO:0007623 | 114 | 0.015 | |
| somatostatin receptor signaling pathway | GO:0038169 | 2 | 0.015 | |
| oocyte construction | GO:0007308 | 2 | 0.015 | |
| cilium assembly | GO:0042384 | 81 | 0.015 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.015 | |
| body fluid secretion | GO:0007589 | 53 | 0.014 | |
| dna modification | GO:0006304 | 50 | 0.014 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.014 | |
| positive regulation of ion transmembrane transport | GO:0034767 | 24 | 0.014 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.014 | |
| engulfment of apoptotic cell | GO:0043652 | 3 | 0.014 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.014 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.014 | |
| positive regulation of blood circulation | GO:1903524 | 22 | 0.014 | |
| regulation of protein localization | GO:0032880 | 231 | 0.014 | |
| ventricular trabecula myocardium morphogenesis | GO:0003222 | 11 | 0.014 | |
| glutamate receptor signaling pathway | GO:0007215 | 35 | 0.014 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.014 | |
| embryonic heart tube development | GO:0035050 | 65 | 0.014 | |
| response to purine containing compound | GO:0014074 | 28 | 0.014 | |
| peptidyl serine modification | GO:0018209 | 83 | 0.014 | |
| regulation of gtp catabolic process | GO:0033124 | 113 | 0.014 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.014 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.014 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.014 | |
| sulfur compound metabolic process | GO:0006790 | 100 | 0.014 | |
| fucosylation | GO:0036065 | 9 | 0.014 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.014 | |
| protein localization to organelle | GO:0033365 | 185 | 0.014 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.014 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.014 | |
| methylation | GO:0032259 | 134 | 0.014 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.014 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.014 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.014 | |
| ubiquitin dependent protein catabolic process via the multivesicular body sorting pathway | GO:0043162 | 3 | 0.013 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.013 | |
| oocyte axis specification | GO:0007309 | 2 | 0.013 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.013 | |
| hormone secretion | GO:0046879 | 128 | 0.013 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.013 | |
| mrna metabolic process | GO:0016071 | 84 | 0.013 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.013 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.013 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.013 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.013 | |
| negative regulation of epithelial cell proliferation | GO:0050680 | 64 | 0.013 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.013 | |
| cytokine production | GO:0001816 | 319 | 0.013 | |
| sodium ion transport | GO:0006814 | 73 | 0.013 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.013 | |
| postganglionic parasympathetic nervous system development | GO:0021784 | 2 | 0.013 | |
| asymmetric neuroblast division | GO:0055059 | 1 | 0.013 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.013 | |
| regulation of cell activation | GO:0050865 | 289 | 0.013 | |
| regulation of proteolysis involved in cellular protein catabolic process | GO:1903050 | 56 | 0.013 | |
| regulation of calcium ion transmembrane transporter activity | GO:1901019 | 20 | 0.013 | |
| enteroendocrine cell differentiation | GO:0035883 | 16 | 0.013 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.013 | |
| cell differentiation in spinal cord | GO:0021515 | 53 | 0.013 | |
| peptidyl threonine modification | GO:0018210 | 31 | 0.013 | |
| somatostatin signaling pathway | GO:0038170 | 2 | 0.013 | |
| inclusion body assembly | GO:0070841 | 3 | 0.013 | |
| b cell activation | GO:0042113 | 161 | 0.013 | |
| coagulation | GO:0050817 | 78 | 0.013 | |
| learning or memory | GO:0007611 | 148 | 0.013 | |
| eye photoreceptor cell differentiation | GO:0001754 | 41 | 0.013 | |
